Related Experiment Video
Updated: Jul 26, 2025
16:13
Modeling Neural Immune Signaling of Episodic and Chronic Migraine Using Spreading Depression In Vitro
Published on: June 13, 2011
20.1K
Strategies for the Management of Spike Protein-Related Pathology
Matthew T J Halma1, Christof Plothe2, Paul Marik3
1EbMCsquared CIC, 11 Laura Place, Bath BA2 4BL, UK.
Microorganisms
|June 15, 2023
Summary
This review examines treatments for long COVID-19 and COVID-19 vaccine injury, both linked to the spike protein. It details treatment options, mechanisms, and evidence for these conditions.
Area of Science:
- Immunology
- Virology
- Vascular Medicine
Background:
- The COVID-19 pandemic has led to two related conditions: long COVID-19 and COVID-19 vaccine injury.
- Both conditions share a potential etiological link to the SARS-CoV-2 spike protein.
- The spike protein can induce harm through various mechanisms, including vascular damage.
Purpose of the Study:
- To review and summarize current treatment options for long COVID-19 and COVID-19 vaccine injury.
- To explore the underlying mechanisms of harm associated with the spike protein in these conditions.
- To evaluate the evidentiary basis for existing and emerging treatment protocols.
Main Methods:
- Systematic literature review of studies on long COVID-19 and vaccine injury treatments.
- Analysis of research on spike protein mechanisms and vascular effects.
- Evaluation of clinical trial data and case reports for treatment efficacy.
Main Results:
- Identified several therapeutic strategies targeting the spike protein and its downstream effects.
- Highlighted the role of vascular dysfunction as a key mechanism in both conditions.
- Assessed the varying levels of evidence supporting different treatment modalities.
Conclusions:
- Effective treatment protocols for long COVID-19 and vaccine injury are crucial due to their prevalence.
- Understanding the diverse mechanisms, particularly vascular, is key to developing targeted therapies.
- Further research is needed to strengthen the evidence base for optimal patient management.
Related Concept Videos
01:14Myocarditis III: Medical Management
9
Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
9
01:28Acute Pyelonephritis II: Diagnostic Studies and Management
19
Introduction:For diagnosing acute pyelonephritis, a comprehensive patient history is collected to identify symptoms such as dysuria, frequent or urgent urination, flank pain, or costovertebral angle (CVA) tenderness that may suggest a kidney infection.Physical ExaminationDuring the physical examination, CVA tenderness is assessed. This involves gentle percussion over the costovertebral angle, where tenderness often indicates a kidney infection.Diagnostic TestsUrinalysis: Used to identify white...
19
01:28Pneumonia IV: Management
399
The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
399